Pfizer Inc

NYSE: PFE
$26.72
+$0.53 (+2.0%)
Closing Price on November 13, 2024

PFE Articles

Apple, DuPont, Goldman Sachs, and Pfizer led the DJIA to a lower close on Tuesday.
The March 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
With the major markets retreating from all-time highs, it began to look like the Trump rally was spent. Judging by the most shorted stocks traded on the New York Stock Exchange, overall short sellers...
24/7 Wall St. has taken a look at a few companies within the health care sector that might have seen a reaction from the health care vote in Congress, or lack thereof.
Goldman Sachs, DuPont, Boeing, and Pfizer weighed on the Dow Jones Industrial Average Friday.
DuPont, Chevron, Merck, and Pfizer sink the DJIA on Thursday.
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.
The bull market is now eight years old, and markets still keep on hitting new highs. How have the short sellers been reacting to this pricey market?
Chevron, Verizon, Pfizer, and Merck combined to weigh on the DJIA Tuesday.
Merck and Pfizer each saw their shares sink early on Monday after the firms gave an update on their type 2 diabetes treatment.
Judging by this report, short sellers are making a tremendous bet against Trump’s plan to reform the health care sector.
The nearly eight-year old bull market endures, with markets recently hitting all-time highs. And how are short sellers reacting?
Johnson & Johnson, Pfizer, UnitedHealth, and Verizon lifted the DJIA on Thursday.
2016's 50 most innovative companies are topped by Apple, Google and Tesla. Among the companies making the biggest moves were Netflix and Facebook, and new entrants on the list included Uber and...
Pfizer, Cisco, JPMorgan, and Procter & Gamble lead the DJIA to another record high on Wednesday.